An enzyme called cyclin-dependent kinase 2 (CDK2) regulates the cell cycle and may have the potential to drive therapeutic ...

The American Cancer Society's chief scientific officer outlines the group's research agenda, including a new project in ...

When blood cancer cells break through the bone and multiply, tumor cells become dangerously diverse and the immune response in the region changes, researchers report. The detailed insights into cancer ...

Interrupting signals exchanged between tumors and the nervous system could become a critical pillar of cancer care ...

Historically, cancer care largely focused on the fight for survival. Now, thanks to advancements in screening and treatment, many patients are living decades beyond their diagnosis.

The funding agency aims to cap “indirect costs” in biomedical research grants. But this behind-the-scenes work is crucial to making research happen.

More than 67,000 Americans will be diagnosed with pancreatic cancer this year. Learn more about the disease and how PanCAN can help.